In particular, previous use of spatial transcriptomics to investigate Cx3cr1‐dependent deletion of Inpp5d, when crossed with APP/PS1 amyloidosis mice, highlighted an extended gene expression signature associated with plaques and identified CST7 (cystatin F) as a novel marker of plaques.90 This evidence concerns the gene CST7 and amyloidosis.